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Abstract: Strains of the malaria parasite, Plasmodium falciparum, have become resistant to 
conventional quinoline-based drugs.  The ancient Chinese remedial herb, Artemisia annua, 
produces a sesquiterpene, artemisinin, which has been used to treat otherwise resistant strains of 
malaria.  Low levels of in planta production of the compound, however, have not been able to 
meet the demand for the product.  In planta production of the anti-malarial drug, artemisinin 
(AN), is enhanced in shoots of Artemisia annua when roots are present.  Roots, however, do not 
produce either AN or its artemisinic precursors. On the other hand, a biochemical precursor, 
artemisinic acid (AA), can be glycosylated in vitro by suspension cells of A. annua.  The 
stimulatory role of roots in the production of AN could, thus, be related to the production of 
glycosylated terpenoids.  This project sought to confirm the presence of conjugated AA in both 
the shoots and the roots of whole plants of A. annua.  Bulk extracts of shoots and roots were 
purified in an attempt to isolate the putative compounds.  Also, extracts were hydrolyzed in order 
to test for increases in the cleaved terpenoids.  Existing AA was first removed from aqueous 
plant extracts which were subsequently hydrolyzed with acid, esterase, or β-
glucosidase.  Cleavage of an AA conjugate should result in increased pools of the cleaved 
product.  Increases were observed in treated shoots after acid hydrolysis and glucosidase 
treatment.  AA was not observed after any treatment of root residues.  Analysis of shoots of A. 
annua showed that putative conjugates may be present in the plant, localized in the shoots.  The 
purified fractions of extracts from bulk amounts of shoots and roots of whole plants analyzed at 
this time do not indicate the presence of detectable amounts of the conjugate, although further 
analysis is required.   
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Background/Introduction 
 
Importance and shortage of artemisinin    
The long-time widespread use of quinolines and the other conventional anti-malarials has 
resulted in the selection of drug-resistant strains of Plasmodium falciparum, one of the malaria 
parasites (Wernsdorfer, 1994).  The ancient medicinal knowledge of the Chinese has fortunately 
presented a “novel” treatment, traditionally made as tea or tincture from the weed-like herb qing 
hao (青蒿) (a.k.a. sweet annie, sweet wormwood, Artemisia annua) and used to treat dozens of 
ailments, including hemorrhoids and many fevers (Abdin et al., 2003).   The active compound, 
the sesquiterpene lactone, artemisinin
1
 (Figure 1), has met no resistance from the malaria 
parasites despite widespread application in recent years (Abdin, et al. 2003), and presents a 
possible solution to the world’s malaria problem.  The greatest obstacle, however, to the 
worldwide application of this drug is its relatively low concentration in planta.  Worldwide 
demand currently exhausts traditional production (Abdin et al., 2003) and ironically, it is difficult 
to cultivate in the tropical areas where it is most needed (Klayman, 1989).  With complete 
chemical synthesis being economically unfeasible, extensive research has focused on 
maximizing the biological production of the compound through various avenues of plant 
biotechnology and metabolic engineering.   
 
                                                 
1
 Abbreviations: AN, artemisinin; AA, artemisinic acid; AB, arteannuin B 
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Figure 1: The chemical structure of Artemisinin 
 
Terpenoid Metabolism in A. annua 
Like other useful aromatic plants, A. annua contains a rich assortment of secondary 
metabolites, terpenoids including artemisinin, and many structurally related compounds (Tan, et 
al., 1998).  There are four major classes of secondary products: the terpenoids, phenolic 
compounds, glycosides and alkaloids.   
The terpenoids, also known as isoprenoids, include about 15,000 known compounds 
produced by many forms of life (Hopkins and Huner, 2004).  One thing that all terpenoids have 
in common is that they are derived by repetitive fusion and cyclization of isopentyl 
pyrophosphate (IPP) and its isomer dimethylallyl pyrophosphate (DMAP).  Terpenoids are 
classified by the number of five carbon units (isoprenes) they contain: hemi-, mono-, sesqui-, di-, 
tri- and tetra terpenes for 1,2,3,6, and 8 isoprenes, respectively.  There are two pathways for the 
production of isopentyl diphosphate, the precursor to all terpenoids.  Plants use both (Martin et 
al., 2003).  The mevalonate pathway converts  acetyl coenzyme A to mevalonate and then to IPP 
and DMAPP.  This occurs in the cytosol.  The non-mevalonate pathway (DXP) is in the plastids 
and in prokaryotic organisms like green algae and eubacteria.  This pathway uses glucose-3-
phosphate and pyruvate to make the precursors (Martin et al., 2003).  Prenyl groups (IPP/DMAP) 
from either pathway may be condensed to farnesyl diphosphate, a sesquiterpene that can then be 
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directed towards a number of pathways, including triterpene and polyterpene production by 
squalene synthase (SQS), or it can be committed to sesquiterpene production by a sesquiterpene 
cyclase (SQC) (Martin et al., 2003).   
 
The Artemisinin Pathway 
 The biochemical steps after amorpha-4,11-diene synthase, the SQC that directs carbon to 
artemisinin, are still being elucidated, but cyclization is known to be the first committed step in 
artemisinin synthesis (Figure 2; Bouwmeester et al., 1999).  A number of artemisinic precursors 
have been isolated, and some corresponding enzymes have been demonstrated in cell-free 
extracts.  Artemisinic acid has been identified as a precursor to artemisinin in more than one 
possible way.  Cell-free extracts were shown by several teams to convert artemisinic acid to 
arteannuin B and then to artemisinin (Abdin et al., 2003).  Dihydroarteannuin B has been isolated, 
and suggested as an intermediate in this step (Abdin et al., 2003).  Alternatively, 
dihydroartemisinic acid has been transformed into artemisinin by cell-free extracts (Kim and 
Kim, 1992) and has also been photochemically converted to artemisinin in vitro with 
dihydroartemisinic acid hydroperoxide as an intermediate (Wallaart et al., 1999a, b).  
Artemisinic acid is considered to be the direct precursor to dihydroartemisinic acid (Wallaart et 
al., 2000), and it appears that there are at least two paths leading from artemisinic acid to 
artemisinin.   
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Figure 2: Proposed biosynthetic pathway of artemisinin  
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In a survey of phenotypically identical A. annua plants from different geographical 
regions, Wallaart et al. (2000) discovered that there are two distinct chemotypes with differing 
relative amounts of artemisinin and its direct precursors artemisinic acid and dihydroartemisinic 
acid (Wallaart et al., 2000).  They found that high levels of artemisinin occur with low levels of 
artemisinic acid and high levels of dihydroartemisinic acid.  In a corollary fashion, geographical 
samples with low levels of artemisinin had high levels of artemisinic acid and low levels of 
dihydroartemisinic acid.  This difference suggested to Wallaart et al. (2000) that the reduction of 
artemisinic acid is a rate-limiting step in the production of artemisinin (Wallaart et al., 2000).  
The team also noted high levels of arteannuin B and epi-deoxyartennuin B in the chemotype with 
increased artemisinic acid, as well as high levels of a product of dihydroartemisinic acid in the 
other chemotype.  These data further demonstrated a chemotypical difference in artemisinic acid 
reduction.  
 
The final production of artemisinin appears to be sequestered in the glandular trichomes 
of the plant.  Correlating with the presence of trichomes, observed levels of artemisinin are 
highest in flowers, then buds and leaves, and lowest in green stems and seeds (Duke et al. 1994; 
Abdin et al., 2003).  A biotype of A. annua without glandular trichomes exhibits no production 
of artemisinin or a possible precursor, artemisitene (Duke, et al, 1994).  There are no glandular 
trichomes on the roots of A. annua.  Although no artemisinin or artemisitene has been detected in 
the roots, it was observed in transformed roots (Liu et al., 1997; Weathers et al., 1994).  Shoot 
cultures initiated from leaf tissue callus do not produce artemisinic compounds until roots are 
also initiated (Fulzele, et al., 1991), and shoots grown in hormone-free medium after root 
removal show a 53% decrease in artemisinin content (Ferreira and Janick, 1996).  Although they 
contain no artemisinin, roots appear to play some role in its production.  The nature of any 
possible precursor transported within the plant is still unknown. 
 
 
 
 
 
 
Is a Precursor to the Anti-Malarial Drug, Artemisinin, Glycosylated in planta?______________________ 
 Driggs, 2006  
 6 
Conjugation 
The diversity of the thousands of secondary metabolites produced by plants is enhanced 
by their ability to decorate the molecules with many different attachments.  The ability to 
conjugate sugars to endogenous and exogenous organic molecules is such a modification 
employed by many organisms.  In a review of glucosyltransferases, Jones and Vogt (2001) 
succinctly describe plant secondary conjugates: 
 
“The addition of a carbohydrate-moiety to endogenous and exogenous 
organic molecules has a wide range of effects including increased water 
solubility, improved chemical stability, reduced chemical reactivity and 
altered biological activity.  Secondary plant metabolites are glycosylated to 
O (OH- and COOH-), N, S and C atoms by glycosyltransferases using 
nucleotide-activated sugars as donor substrates.  Hydroxylated molecules 
are the most common acceptors, whilst UDP-glucose is the most common 
donor.  A broad range of different carbohydrate moieties can be added 
employing all forms of sugars, independently (monoglycosides), in parallel 
or in chains (di, tri-glycosides, etc).  This gives rise to a broad spectrum of 
glycosidic structures for any given aglycone.  For example, out of a total of 
5,000 different flavanoids, 300 different glycosides of one single flavonol, 
quercetin, have already been identified” (Jones and Vogt, 2001) 
 
Plants are able to glycosylate harmful secondary metabolites as a means of detoxification 
(Pedras et al., 2000).  The electron draw of the sugar residue serves to convert a reactive and 
toxic aglycones to a more stable and less reactive form, sequestering the compound from other 
cellular components (Jones and Vogt, 2001).  The addition of sugars to terpenoids makes them 
less volatile (Aharoni et al., 2003). 
The glycosylation of secondary metabolites may have a biological effect in signal 
recognition, transport and metabolism, affecting the molecule’s interactions with other molecules, 
signal receptors, transport proteins or degradative enzymes (Jones and Vogt, 2001).  It plays a 
role in plant defense, allowing toxic chemical weapons to be pre-made, put on “stand-by”, often 
localized within the point of environmental interaction: the surface cells (Osbourn, 1996).  For 
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example, oats (Avenus) produce glycosylated saponins in the root epidermal cells which yield 
antifungal aglycones upon cleavage, which is stimulated by wounding of the cells (Osbourn, 
1996).   
Glycosylation also plays a role in intraspecies and interplant signaling.  Cleavage of the 
flavanol glycosidic forms of kaempferol and quercetin is necessary in order to induce pollen 
germination in maize and petunia (Jones and Vogt, 2001).  Glycosylation plays a role in plant 
hormones, as well, not only mediating turnover but also allowing for their temporary 
deactivation, conserving resources and decreasing response time (Jones and Vogt, 2001).   
Understanding the glucosyltransferase (GT) responsible for modifying a secondary 
metabolite is critical to understanding the role that glycosylation has to play in the plant.  How 
specific is the activity of the particular enzyme, and how is the enzyme regulated?  Jones and 
Vogt (2001) report that “several putative and verified GT-encoding genes have been found to be 
induced by methyl jasmonate, salicylic acid and wounding.  The induction was both rapid and 
transient in several of these cases” (Jones and Vogt, 2001).  A light response has also been 
observed (at the level of mRNA) to play a role in glycosylation, and developmental responses as 
well (Jones and Vogt, 2001).  Further, GTs may exist as part of the enzymatic complex 
(metabolon) of a metabolic pathway (Jones and Vogt, 2001).   
 The sesquiterpene lactone artemisinin has an endoperoxide bridge.  This is the functional 
unit that provides the mechanism of action against the Plasmodium parasites, but also confers a 
degree of plant inhibition, or phytotoxicity (Dayan et al., 1999).  The phytotoxic nature of 
artemisinin and prevalence of its production in A. annua suggests that some methods of 
sequestration might exist.  It has already been established that artemisinin is physically 
sequestered in the trichomes, but it is not confirmed if all the final stages of synthesis occur 
solely in the trichomes.  If precursors are transported within the plant, then some means of 
decreasing compound volatility would be needed.  The transportation of glycosylated secondary 
metabolites is documented, and in some plants, some secondary metabolites are transported only 
if they are glycosylated (Jones and Vogt, 2001).  For example, the iridoid (terpene) glycoside, a 
defense compound in Asarina scandens has been shown to be transported in the phloem (Gowan 
et al. 1995).  In Arabidopsis, radiolabelled glycosides applied to the leaf surface of plants was 
shown to be distributed to all parts of the plant through source-sink transport (Chen, et al. 2001). 
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Prior Studies 
 
Three preliminary studies have been performed at WPI in a search for a glucose 
conjugate of artemisinin.  Knapp (2001) performed chemical hydrolysis (acid/base) and 
enzymatic hydrolysis (esterase, β-glucosidase, and β–glucuronidase) of aqueous extracts of 
transformed roots of A. annua. If conjugates of artemisinin were present, then such cleavage 
activities should have increased available levels of the aglycon.  However, because he failed to 
use a co-injection of an untreated artemisinin standard in his HPLC, the variation of replicate 
assays rendered the results inconclusive.  Bullis (2002) repeated much of this work, but because 
of the overall dismal production of artemisinin in the transformed roots at the time, no 
observable increase was observed after enzymatic treatment.  In work performed by Driggs 
(2004, unpublished) aqueous extracts of whole plant shoot tissues, with significant levels of 
endogenous artemisinin, showed no increase after treatment with β-glucosidase, and β–
glucuronidase.  These data suggested that if there were conjugates of artemisinin in A. annua, 
they were not susceptible to cleavage and/or were not present in any detectable amount.  Upon 
considering the chemical structure of artemisinin, it was observed that there isn’t a conjugate that 
would be chemically likely.  With a closed lactone ring in artemisinin, there is no active 
functional group that would react with a sugar.  On the other hand, precursors of artemisinin, 
including artemisinic acid, exhibit a hydroxyl group that could allow condensation with sugar.   
Kawamoto et al., (1998) found that A. annua has the enzymatic ability to glycosylate 
artemisinic acid.  When a suspension culture of A. annua cells was fed artemisinic acid, three 
glucopyranosyl esters (Figure 3) of artemisinic acid were isolated.  AA-G1(Figure 3) was exuded 
by the cells into the media, while the other two (AA-G2 and 3) were extracted from the cells.  
The production pathway for artemisinin in these cells was not fully functional, however, because 
no artemisinin or artemisinic acid was detected before addition of artemisinic acid, and no 
artemisinin was detected with the three glucosyl esters.  Kawamoto et al. (1998) suggested this 
glycosylation is a possible detoxification mechanism.  Unfortunately Kawamoto did not search 
for the compound in whole plant tissue (Kawamoto 2005, personal communication, Appendix A).    
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AA-G1        AA-G2                               AA-G3 
AA-G1, artemisinic acid B-D-glucopyranosyl ester; AA-G2, 9-B-hydroxyartemisinic acid B-D-
gluco-pyranosyl ester; AA-G3, 3-B-hydroxyartemisinic acid B-D-glucopyranosyl ester 
(Kawamoto et al., 1998) 
 
Taken together with the possibility that the reduction of artemisinic acid is a rate-limiting 
step in artemisinin production (Wallaart et al., 2000), sequestration of this precursor could play 
an important role in the regulation of artemisinin production.  Since the final two steps in the 
transformation of dihydroartemisinic acid to artemisinin have been shown to occur 
spontaneously through photooxidation, control at the point of artemisinic acid reduction would 
be the last biochemical opportunity to influence final production of artemisinin in this pathway.    
 From Kawamoto’s work, it is clear that glycosylated precursors of artemisinin could also 
exist in the whole plant, and along with the role that roots appear to have in stimulating 
artemisinin production (Ferreira and Janick, 1996), it may be possible that such glycosylated 
precursors are manufactured both in the roots and the shoots.  Therefore this study will include a 
search for glycosylated artemisinic acid in both the roots and shoots of whole plants.   
 
 
 
 
 
 
 
Figure 3: The biotransformation products of artemisinic acid: 
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Hypotheses 
 
 Prior research conducted at WPI, the work of Kawamoto et al. (1998) and other 
information in the primary literature has led to the following hypotheses: 
 
1. If conjugated forms of artemisinic acid exists in whole plant tissues of A. annua, then 
chemical or enzymatic hydrolysis of an extract residue will increase free artemisinic 
acid. 
2. If the glucosyl esters identified by Kawamoto et al. (1998) exist in whole plant 
material of A. annua, then they can be isolated and identified using the same methods.   
Objectives 
 This investigation of whole plant tissues of A. annua has three objectives: 
  
 1.  To confirm the presence of conjugated forms of artemisinic acid.. 
2.  To confirm the presence of glucosyl esters AA-G1, AA-G2, AA-G3. 
 
 
Methods 
 
Plant Growth 
 
Artemisia annua (strain YU16) plants were grown from seed originally supplied by  
Dr. Nancy Acton, Walter Reed Army Institute for Research.  Plants were grown in a soil-less 
media (SunGro MetroMix 360) under high intensity cool white fluorescent lights running on a 
flower-inhibiting photoperiod (short night; 16 hr light:8 hr dark) in a temperature-controlled 
growth chamber (24˚C).  Plants received regularly weekly fertilizations (Miracle Grow complete 
fertilizer, half-strength).   
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Figure 4: Flowchart depicting the purification procedure as explained in the text. 
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Putative Glycoside Isolation from Shoots and Roots of A. annua Plants 
 
The isolation of putative glyco-conjugates of artemisinic acid was carried out as described by 
Kawamoto et al. (1998) and as clarified through personal communications with Kawamoto in 
2005 (See Appendix A).  Specific separation methods were performed as interpreted by       
Dr. Karen Erickson, a natural products chemist at Clark University, Worcester, MA.   
Fresh material from 53 mature plants of A. annua was harvested.  Shoots were separated 
from roots, and the latter cleaned of growing media.  Leafs with petioles were removed from the 
stems of the plant.  Total fresh mass of 521.29 g of leaves and 245.39 g of roots were obtained 
and lyophilized to yield 126 and 36.17 grams dry weight (DW), respectively.    This mass is well 
above the 55 g DW mass of suspension cells of A. annua from which 10 mg to 58 mg of 
conjugate were previously isolated by Kawamoto et al. (1998).   
The dried leaves (shoots) were crumbled to a coarse powder in a Ziploc bag.  The roots 
were ground to a dust in liquid nitrogen with a mortar and pestle.  The roots and shoots were 
separately extracted three times with hexane, sonicating in ice for 30 minutes with fresh solvent 
each time.  This was done in order to remove very non-polar molecules from the matter, 
including free terpenoids.  These three hexane extracts were pooled (Fig. 4, Hr and Hs).  The 
extracted plant material was then extracted again using ultrasonics, but with ethyl acetate solvent 
(Kawamoto et al, 1998).  After the third extraction, the plant material sat in the solvent of the 
third extraction for 48 hours at about 25 ˚C on the bench-top (in the lab under the room’s 
fluorescent lights).  Extracts (Figure 4, EAr and EAs) were then pooled.  All extracts were 
evaporated under reduced pressure at 35 °C to obtain the following crude residues: 0.28 g 
hexane-extracted root residue (Hr), 0.73 g ethyl acetate-extracted root residue (EAr), 2.91 g 
hexane-extracted shoot residue (Hs) and 8.46 g ethyl acetate extracted shoot residue (EAs).  
Samples were stored at 4°C until further analysis.  
The crude ethyl acetate residues, EAr and EAs, were dissolved in n-butanol saturated with 
water, and washed three times with sodium chloride saturated water to remove very polar 
molecules.  The aqueous fraction was frozen for later analysis, and the butanol layer was 
evaporated under reduced pressure to obtain two washed residues (8.15 g washed shoot residue, 
BWs, and 0.64 g washed root residue, BWr).     
 Both fractions (BWs and BWr) were further purified using vacuum liquid chromatography, 
as follows.  A 150 ml fritted disc funnel (dimensions 4.5 cm H x 7.5 cm W) was packed with 
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type 60 H silica gel and rinsed with petroleum ether.  A newly packed column was used for the 
separation of each 1.5 g aliquot of shoot residue (BWs).  The entire BWr root residue was applied 
at once.  Each BW sample was dissolved in chloroform with a few drops of petroleum ether, in 
about 5 ml, and quickly applied to the column, with the vacuum off, and then dried by removing 
the solvent by vacuum suction.  A series of solvents, increasing in polarity, were sequentially run 
through the column, with aliquots collected separately in vacuum flasks in the following order: a 
200 ml wash of chloroform/petroleum ether wash, two 200 ml aliquots of 100% chloroform, two 
200 ml aliquots of 90:10 chloroform/methanol, two 200 ml aliquots 80:20 chloroform/methanol, 
and one final 200 ml wash of 50:50 chloroform/methanol.  This process was repeated until all of 
each of the BWs had been applied and eluted.  The corresponding fractions for each separation, 
for example, all of the first fractions with 100% chloroform, were pooled and evaporated under 
reduced pressure.   
 Kawamoto et al. (1998) reported that the conjugates found in cell tissues were eluted with 
the 80:20 solvent mix, so both of these fractions were further purified by HPLC, using a 150 X 
4.6 mm C18 Column, eluted isocratically with acetonitrile/water (1:4) mobile phase at 1 ml/min 
and monitored at 220 nm.  According to Kawamoto, the two glucosyl esters found in suspension 
cells, AA-G2 and AA-G3, were expected to elute at 22 and 29 minutes (ml), respectively.  A 
fraction collector was set up to collect the eluent in 30 second (0.5 ml) fractions.  Fractions 
representing peaks of interest were pooled and lyophilized.  The fractions of interest were 
transferred with chloroform to sealable containers and dried under nitrogen.  These samples were 
then transferred to Karen Erickson at Clark University for NMR analysis. 
 
 
Enzymatic and Acid Hydrolysis of Putative AA Glycosides 
 
Any putative terpenoid glycosides like those reported by Kawamoto et al. (1998), (see 
Figure 3), should be susceptible to hydrolysis of the terpenoid from its sugar using a number of 
different methods, including the enzymes, β-glucosidase (E.C.3.2.1.21, Fluka Prod. No. 49290) 
and carboxyl esterase (E.C. 3.1.1.1, Sigma Prod. No. E-3019), or a strong acid (1M HCl).  A 
positive result would show an increase in free artemisinic acid once the sugars are cleaved.  An 
Is a Precursor to the Anti-Malarial Drug, Artemisinin, Glycosylated in planta?______________________ 
 Driggs, 2006  
 14 
artemisinic acid and an arteannuin B standard treated with any experimental hydrolysis methods 
should provide a control for any aberrant affects on the terpenoids.   
 
 
Figure 5: Flowchart depicting the preparation of hydrolysis samples. 
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As displayed in Figure 5, fresh biomass from 7 mature plants of A. annua was harvested.  
Shoots were separated from roots, and the latter were cleaned of growing media.  Leaves with 
petioles were removed from the stems.  Total fresh mass of 6 g of leaves and 19.2 g of roots were 
obtained and lyophilized.  These plant fractions were separately extracted three times with ethyl 
acetate, sonicating in ice for 30 minutes with fresh solvent each time.  The extracts were pooled 
and then evaporated under reduced pressure at 35 °C to obtain the following residues: 0.125 g 
shoot residue, 0.085 g root residue.  Samples were stored at -18°C until further analysis.  
Because this experiment measured an increase in free artemisinic acid, and A. annua 
leaves normally contain endogenous pools of artemisinic acid (AA), a method was developed to 
remove free AA to facilitate measurement of AA that was produced as a result of enzyme or acid 
cleavage of any putative glycosides.  A modified version of the separation techniques of 
Vonwiller et al. (1993) was used to remove AA and other acidic compounds from the shoot 
residue.  The prior ethyl acetate extracts were first dissolved in 8 mls of diethyl ether and then 
washed 6 times with 9 ml of a 5% (w/v) potassium carbonate aqueous solution.  The 
appropriateness of the wash procedure for separating AA from terpene glycosides was confirmed 
previously using a  mixture of standard AA and the triterpene glycoside, digitoxin (data not 
shown).  The ether fraction was dried to obtain the washed shoot residue.  The washed shoot 
residue was split 32 ways by completely dissolving it in 65 ml of ethyl acetate and removing 1 
ml at a time.  This was done twice.  The root residue was split similarly into 1 ml aliquots, 16 
ways, twice, with 32.5 ml ethyl acetate.   
Each of the separated residues was treated according to the methods of Enyedi et al. 
(1992) as follows.  Using a 2 minute pulse of ultrasonics, residue fractions were resuspended in 4 
ml of the respective solvent.  As shown in Table 1, twenty-two paired aliquots of the washed 
shoot residue were treated with 11 conditions.  A non-treated condition served as a reference; the 
sample was immediately analyzed by HPLC for AB and AA.  A suspension in a neutral buffer 
(0.2 M sodium phosphate, pH 7.0), or in each of the two enzyme buffers (see below), was 
extracted immediately to determine the effect of that pH and buffer on the extract.  Enzymatic 
hydrolysis was performed for 90 minutes at 37°C in 4.0 ml of leaf extract resuspended in 
hydrolysis buffer (10 mM borate buffer, pH 8.0 for esterase; 100 mM sodium acetate buffer, pH 
5.0 for glucosidase, per Sigma-Aldrich quality control test procedures, available as part of the 
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on-line catalog) containing 20 units of each of the respective enzyme.  Residue fractions were 
also resuspended in each of the enzyme buffers without the enzyme, and incubated at 37°C for 
90 minutes concurrent with the other samples.  Acid hydrolysis was performed in 4 ml 1N HCl at 
80°C for 30 minutes.  To determine the effect of the strong acid and the high temperature, 
independently, residue fractions were subjected to each condition separately (one at room 
temperature, and one with neutral buffer).  Seven of these conditions, as explained in Table 1, 
were also carried out in duplicate on aliquots of the root residue.  To end incubation for each 
condition, the sample was placed on ice and immediately extracted three times with toluene.  
Each of the conditions listed in Table 1 was also tested on a 20 ug standards of artemisinic acid 
and arteannuin B, in order to determine the effects of each treatment on existing artemisinic acid 
and arteannuin B.  One-tenth fractions of these test residues were injected into the HPLC. 
To develop a reasonable method, the cleavage activity of the three different treatments 
was first investigated using a glycoside standard, digitoxin, a steroid (triterpene) attached by an 
ether bond to a chain, of three sugar molecules, and analyzed with TLC (data not shown).  Use of 
this terpenoid glycoside enabled somewhat of an optimization of the methods of hydrolysis 
conditions, especially for the acid hydrolysis method. 
The specific activity of each of the enzymes used in this study was confirmed in the 
respective experimental conditions.  The activity of glucosidase was confirmed by the cleavage 
of a known substrate, p-nitrophenyl-B-D-glucopyranoside, causing an increase in absorbance at 
410 nm (per Sigma Aldrich).  Esterase activity was confirmed in a similar fashion, with 
fluorescein-diacetate as a substrate causing increased absorbance at 495 nm (Weathers and Kim, 
2001).   
Quantitative analysis of AA and AB 
Assay of AA and AB was performed using HPLC, according to the modified method of 
Roth and Acton (1989).  Samples in acetonitrile were separated with a C-18 column (25 cm x 4.6 
cm l x d) in acetonitrile-water (60:40) and detected at 220nm.  Peaks of interest were compared 
to authentic AA and AB standards.   
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Table 1: Experimental treatment conditions for washed shoots, roots, arteannuin B standard  
and artemisinic acid standard. 
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Results 
 
 In order to determine whether or not a naturally occurring AA glycoside is present in A. 
annua plants, two different experimental approaches were used.  First, large masses of roots and 
shoots from vegetativly grown plants were extracted and separated into fractions for NMR 
analysis.  Alternatively, if any AA glycosides exist in planta they should be susceptible to 
hydrolysis of the glycosidic bond linking the sugar to the terpenoids, resulting in increased pools 
of free AA.  Results from both experimental approaches are described.   
 Putative Glycoside Isolation from Shoots and Roots of A. annua Plants 
 Based on the work of Kawamoto et al. (1998), the putative AA conjugates were expected 
to be found in the 80:20 Chloroform-methanol fraction (Figure 4).  The 80:20 fractions (shoots 
and roots) were the only fractions pooled and analyzed by NMR (as shown in Figures 6 and 7). 
 The residue (74 mg) from the purified shoot fraction, (80:20 Sa), when separated by 
HPLC resulted in the chromatogram displayed in Figure 6.  The sample was applied in two 
injections of 200 ul each.  The eluted fractions gathered using the fraction collector were pooled 
into 6 groups, labeled “c” through “i" in Figure 6.  The six pooled fractions from the  2 injections 
(c through i), represented the peaks detected at 220 nm between 13.5 minutes and 31.5 minutes, 
and were transferred to Dr. Karen Erickson at Clark University for NMR analysis.  The final 
mass of each pooled residue is listed in Table 2 and in total represented 9 mg of the total 74 mg 
of 80:20 Sa.  
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Table 2: Masses of pooled residues 
after separation into 6 peaks eluted off 
the HPLC column. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The purified root fractions, 80:20 Ra and 80:20 Rb, were pooled together yielding a 
combined weight of 42 mg.  Separation by HPLC resulted in the chromatogram displayed in 
Figure 7.  The sample was applied in two injections of 100 ul each.  The eluted fractions were 
collected and pooled as labeled in Figure 7.  The six pooled fractions, labeled “m” through “q" in 
Figure 7, representing the peaks detected between 15 minutes and 43 minutes, were transferred 
to Dr. Karen Erickson at Clark University for NMR analysis.  The final mass of each pooled 
residue was unfortunately barely detectable (≤ 1 mg).   
 
Fraction 
letter 
Final mass  
c 2 mg 
d 2 mg 
e 1 mg 
f/g 2 mg 
h 1 mg 
i 1 mg 
Figure 6: Chromatogram of shoot fraction 80:20a separated by 
HPLC.  The letters represent the eluted fractions that were 
pooled from two identical injections. 
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Figure 7: Chromatogram of root fraction 80:20 separated  
by HPLC.  The letters represent the eluted fractions that were pooled  
from two identical injections. 
 
The NMR analysis of pooled fractions from both the HPLC-purified shoots and the roots 
did not indicate the presence of glycosylated terpenoids.  Rather, the results suggested that only 
fats were present in the samples (data not shown). 
 
The majority of the purified shoot and root extracts were in the 90:10 fractions, which 
were not separated by HPLC or analyzed by NMR.  The shoot fractions weighed 5.1 grams 
(90:10As, Figure 4) and 0.619 grams (90:10Bs, Figure 4), in total representing 70% of the semi-
crude residue applied to the chromatography column in the last step of purification.  The 90:10 
root fractions were 0.18 and 0.11 g (90:10 Ar and Br, respectively, representing 45% of the total 
root residue applied).  In contrast, the residues that were analyzed in this report, the 80:20 
fractions, were only 74 mg and 18 mg (shoots and roots, respectively) before being separated by 
HPLC.  If an error was made in the interpretation or the application of the isolation methods of 
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Kawamoto et al. (1998), then the compounds of interest may have ended up in a different 
fraction.  The 90:10 fractions should be the next place to search, but time restricted the extent of 
this project.  
Enzymatic and Acid Hydrolysis of Putative AA Glycosides 
 
 If any artemisinic acid glycosides exist in planta they should be susceptible to hydrolysis 
of the glycosidic bond linking the sugar to the terpenoids, resulting in increased pools of free AA.  
The hydrolysis conditions used in this study were first tested on standards of AA and AB to 
determine the extent of degradation due to these treatments.  The shoot and root extracts were 
subsequently subjected to the same conditions in a search for those increased pools of AA.  The 
results of HPLC analysis of these 
experiments are presented. 
Hydrolysis of Standards 
AA and AB 
The different extractions 
clearly showed some specific and 
degradative effects on the pure 
standards AA and AB as shown 
in Figure 8 and 9, respectively.  
When 20 ug of AA (an aliquot 
representing 2 ug was analyzed) 
was exposed only to a 0.2 M 
sodium phosphate buffer, pH 7.0, 
17.3% of AA was lost (Figure 8).  
However, it did not appear that 
prolonged exposure to heat 
(80°C for 30 min) resulted in any 
further loss.  The standard was 
not further degraded by esterase, 
and appeared to be slightly more 
           Figure 8: Effects of hydrolysis conditions on artemisinic acid standard 
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stable in the glucosidase buffer.  A treatment with hot acid, however, resulted in the loss of 73% 
of the standard.  Although this sample set was not replicated, similar results were obtained in the 
past (data not shown).   
 
 
 
The treatment of arteannuin 
B standard (Figure 9) with 
the hydrolysis conditions 
resulted in the apparent 
formation of artemisinic acid.  
Degradation of AB could 
thus yield the chemically 
related AA.  For the purpose 
of comparison, the observed 
quantities of AA (calculated 
based on the absorbance 
value of AA standard) were 
given a percent value based 
on the amount of AB 
originally present.  No AA 
peak was detected in the 
untreated sample, and a small 
amount (2.9%) was detected 
in the immediate extract which also had a 6.7% decrease in AB.  The room temperature acid (1M 
HCl for 30 min.) treatment degraded the AB by 60.7% and caused the appearance of 24.8% AA.  
The hot acid treatment (80°C) completely degraded the AB, but yielded 17.5% AA.  This yield 
was similar to the 21.2% of the AA remaining after the same treatment of the pure AA standard 
(Figure 8).  It is as if the AB was completely converted into AA and subsequently degraded as 
before.  The hot buffer (pH 7.0, 80°C, 30 min) caused little degradation of AB (4.5%) and the 
formation of 10.7% AA.  Curiously, the increase in putative AA after the enzymatic treatments 
      Figure 9: Effects of hydrolysis conditions on arteannuin B standard 
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(42% and 44.3% for esterase and glucosidase, respectively) was much greater than the decrease 
in AB (16.9% and 6.7%, respectively) for those treatments.     
 These changes in AA and AB standards that were observed after the various treatments 
were used to better quantitate AA and AB remaining in the experimental plant extracts. 
Hydrolysis of Root and Shoot Samples 
 
 The root and shoot extracts were prepared and treated as explained in the methods.  The 
HPLC data obtained from the resulting samples were analyzed for changes in AA and AB.  The 
analysis of chromatograms was complicated by the presence of a double peak at the retention 
times for both standards.  While no AA or AB was observed upon treatment of root residues, 
changes were observed in the levels of AA across the conditions, as previously explained. 
The HPLC chromatograms displayed in Figure 10 are representative of the samples 
treated with the 3 hydrolysis conditions.  The complete set of chromatograms is contained in 
Appendix B.  The retention times for the AB and AA standards are displayed in Figure 10A.  
The chromatograms of AA samples in this trial were irregular in baseline and area (Appendix B), 
but the retention time of the apparent AA peak was consistent along with the variations noted in 
the AB standard retention times as shown in Figure 10A.  The chromatograms of the regular pure 
AB standard injections exhibited single-peaks (Figure 10A, B).  The non-treated and treated AB 
standards, however, exhibited double-peaks; compare Appendix B-4 with B-22.   
Analysis of the chromatograms was complicated by the occurrence of an unresolved 
double peak at the retention times for both AA and AB.  This shouldered peak was not observed 
with a more polar mobile phase (80:20 water-acetonitrile).  It was determined that the double-
peak most likely represents a slightly modified form of the respective artemisinic compound that 
is visible as a single peak in the more polar mobile phase.   Considering that the double peak was 
observed in samples that contained only authentic standard (Figure 10C), the area of the entire 
double-peak was used for consistent analysis of results.  The trends obtained from this method of 
analysis correlated strongly with those obtained by estimating the value of the single peak, 
separately.  The retention times, peak areas, and corresponding equivalence of AA and AB are 
detailed and calculated for both single and double peaks in Appendix C.   
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Figure 10:  Representative Chromatograms 
All chromatograms are from the same HPLC run, 
using 60:40 ACN-water A)The overlaid elution 
profiles of all AB standards used during the HPLC 
analysis.  Inset table describes the retention times 
for all injections of both AB and AA.  B) The 
single-peak observed in AB standard against 
double-peak of non-treated washed shoot sample.  
The retention time of the 2
nd
 predominant peak in 
the double-peak was consistently close to that of 
the normal (single) AB standard peak.  C)  Non-
treated AB standard and immediately extracted AB, 
both displaying putative AB double-peak and only 
the later displaying putative AA double-peak  
D) Non-treated and immediately extracted washed shoot residues.  The dramatic increase in the putative AA 
peak is evident after resuspension in pH 7.0 buffer.  E) The root treatments displayed no new peaks at the 
retention times for either    AA or AB.  
 
 
 
 
 
 
 
 
AB std 
AB in washed material 
AB  
AA (only in 
treated) 
AA (only in treated) 
AB  
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Hydrolysis of washed shoot residues: effects on AA 
 
 In order to determine the effect of the 3 hydrolysis methods on any putative AA 
glycosides, one has to be able to quantitatively measure any increases in free AA pools within 
the test samples.  Considering that it is likely that only small amounts of glycosides may be 
present, removal of native free AA would facilitate detection, thus samples first had free AA 
pools removed before proceeding with any of the hydrolysis methods.  The free carboxylic acid 
groups on AA make it very soluble in the carbonate wash used to remove endogenous pools of 
AA.   
The hydrolysis of shoot residues as listed in Table 1 produced some dramatic changes in 
artemisinic acid (Figure 11).  The washed shoot residue showed minimal endogenous AA (8.32 
ug AA/g FW ± 0.27) remaining, demonstrating that the washing procedure was reasonably 
effective (Figure 11) and that only about 2% of the original AA remained.  Un-washed, air-dried 
shoot tissues contained 390 ug/g FW (data not shown).  Surprisingly, however, the immediate 
extraction of the buffer (pH 7.0) suspension of washed shoot residue resulted in an apparent 
dramatic increase in AA to an average of 2269 ug AA/g FW (Figure 10D).  Immediate extraction 
of residues suspended in the other two buffers used in the enzyme experiments (esterase buffer, 
pH 8.0 and glucosidase buffer, pH 5.5) also resulted in increased levels of AA compared to the 
untreated washed control, but considerably less than that observed at pH 7.0.  Clearly, this 
apparent pH effect needs to be investigated further in order to fully understand these results.  
When the washed shoot extracts were incubated for 90 minutes in glucosidase buffer or esterase 
buffer only (without enzyme), the amount of extractable AA decreased compared to extraction 
under the same conditions immediately extracted (Figure 11).  No apparent increases in AB 
occurred in these samples.  Responses of AB to these treatment conditions of plant extracts are 
discussed later. 
Although one of the esterase-treated washed shoot residues displayed AA levels that 
nearly doubled compared to the amount detected in the enzyme-free control (10 mM boric acid 
buffer, pH 8.0), the replicate sample indicated degradation of AA, resulting in an averaged 11% 
increase in AA due to the enzyme (Table 3).  The apparent increase in AA due to glucosidase, 
when compared to the enzyme-free control (100 mM sodium acetate buffer, pH 5.5), was 
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substantial and repeatable (average 72.3%, an increase of 167 ug AA/g FW).  The washed 
residues treated with hot (80°C) pH 7.0 sodium phosphate buffer resulted in a 51.9% decrease in 
AA when compared to the immediate extract with the same buffer.  The acidic treatment (1M 
HCl) at room temperature (25°C, for 30 min) displayed lower levels of AA (32% lower than the 
hot buffer).   
In order to review the changes in AA and AB caused by the different treatment 
conditions of the shoot residues, the values are summarized in Table 3.  Percent changes are 
displayed for meaningful pairs of conditions, as listed in the column labeled “% change 
compared to.”   
Interestingly, the condition combining high heat and low pH (1M HCl at 80°C for 30 
minutes) resulted in levels of AA which were higher than the hot buffer by an average of 7.3%.  
The acid appears to cause an increase in AA when combined with the high temperature.  
Treatment of AA standard with the hydrolysis condition (Figure 8) shows that AA is degraded 
significantly by the hot acid treatment.  If the amount of AA detected in washed shoot residues 
after the hot acid treatment is adjusted for this amount of degradation detected in the standard, 
the resulting amount of AA is actually 4337 ug AA/g FW, which is even higher than the amount 
of AA detected in the immediate extract with neutral buffer.     
Hydrolysis of washed shoot residues: effects on AB 
 
The resulting quantities of AB detected after hydrolysis of shoot residues are displayed 
below, in Figure 12.  The peaks were identified as AB based on their retention time.  Changes in 
retention times over the course of sample injections were accounted for by regular injections of 
authentic standards.  After the shoot residue was essentially washed to remove free AA, rather 
large endogenous AB (646 ug/g FW ± 7.55) remained.  There was no increase in AB upon 
treatment of washed shoot residues with aqueous buffers.  In contrast to what was observed for 
AA, there was no difference in the level of AB in the immediate extracts at any of the three 
different pHs used (Figure 12).  Similar to the treated AB standards, AB decreased by less than 
10% in all conditions except those that were acidic.  The room temperature acid resulted in a 
17% decrease in AB compared to the pH 7.0 buffer incubated at 80°C for the same amount of 
time.  Similar to what was observed for AB standard (Fig. 9), AB was fully degraded by the hot 
acid condition.     
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        Table 3: Hydrolysis effects on AA and AB in washed shoots 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T
a
b
le
 3
: 
 H
y
d
ro
ly
si
s 
ef
fe
c
ts
 o
n
 A
A
 a
n
d
 A
B
 i
n
 w
a
sh
ed
 s
h
o
o
ts
: 
T
h
e 
p
er
c
en
t 
in
cr
ea
se
 i
s 
th
e 
in
cr
ea
se
 i
n
 A
A
 o
r 
A
B
 i
n
 e
a
ch
 c
o
n
d
it
io
n
 i
n
 c
o
m
p
a
r
is
o
n
 t
o
 
th
e 
a
p
p
ro
p
ri
a
te
 r
ef
er
en
ce
 a
s 
li
st
ed
 i
n
 t
h
e 
“
co
m
p
a
re
d
 t
o
”
 c
o
lu
m
n
. 
 V
a
lu
es
 m
a
rk
ed
 “
*
”
 a
re
 n
o
 d
if
fe
re
n
t 
th
a
n
 0
%
 d
u
e 
to
 r
ep
li
ca
te
 v
a
ri
a
ti
o
n
. 
 
R
el
a
ti
v
e 
in
cr
ea
se
s 
in
 A
A
 a
re
 c
o
m
p
a
re
d
 t
o
 c
o
rr
es
p
o
n
d
in
g
 d
ec
r
ea
se
s 
in
 A
B
 i
n
 o
rd
er
 t
o
 c
o
n
si
d
er
 t
h
e 
p
o
ss
ib
il
it
y
 o
f 
a
 c
o
n
v
er
si
o
n
 b
et
w
ee
n
 t
h
em
. 
 
 
Is a Precursor to the Anti-Malarial Drug, Artemisinin, Glycosylated in planta?______________________ 
 Driggs, 2006  
 28 
 
0.00
500.00
1000.00
1500.00
2000.00
2500.00
3000.00
3500.00
4000.00
N
o 
Tr
ea
tm
en
t
Im
m
ed
ia
te
 e
xt
ra
ct
 (p
H
 7
.0
)
Im
m
ed
ia
te
 e
xt
ra
ct
 (p
H
 8
.0
)
pH
 8
.0
 B
uf
fe
r 
on
ly
, 9
0 
m
in
E
st
er
as
e
Im
m
ed
ia
te
 e
xt
ra
ct
 (p
H
 5
.5
)
pH
 5
.5
 B
uf
fe
r 
on
ly
, 9
0 
m
in
G
lu
co
si
da
se
pH
 7
.0
 H
ot
 B
uf
fe
r,
 3
0 
m
in
R
oo
m
 T
em
p.
 A
ci
d,
 3
0 
m
in
H
ot
 A
ci
d,
 3
0 
m
in
Treatment Conditions
u
g
 A
A
 p
e
r 
g
 F
W
AB Remaining after Hydrolysis of Washed Shoot Residues
 
             Figure 11: Effects of hydrolysis conditions on AA in washed shoot residues. 
 
Although the possibility of the conversion of AB to AA due to hydrolysis conditions was 
seen in the standard treatments, such an effect can not account for the sometimes large increases 
in AA seen in the washed shoot residues (Table 3).  The decreases in AB resulting from the 
hydrolysis of the shoot extracts was much lower than the increases in AA resulting from the 
corresponding conditions.  The glucosidase treatment caused an apparent (but minor) increase in 
AB, while also causing an increase in AA.  The amount of AA detected after hot acid treatment 
of shoot extract could not be fully accounted for as the product of degraded AB, since the 
detected level of AA was much higher than the endogenous levels of AB.  The average increase 
in AA due to esterase, when compared to the esterase buffer alone (42 ug AA/g FW) does 
correlate with the apparent decrease in AB due to esterase (41 ug AB/g FW), however, the two 
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values used to obtain the average increase in AA were highly divergent, with one value showing 
a large increase of 337 ug and the other showing a 253 ug decrease. 
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Figure 12: Effects of hydrolysis conditions on AB in washed shoot residues. 
Hydrolysis of root residues 
 
There was no increase in absorbance at the respective retention times for AA or AB in 
any of the root extracts treated with acid, esterase, or β-glucosidase.  No peaks existed at the 
corresponding retention times either before or after hydrolysis treatment, although subtle 
increases may have been obscured by neighboring peaks.  The only noteworthy modification in 
chromatogram profiles resulted from treatment with hot acid, where all the HPLC peaks 
decreased in absorbance, and some new peaks appeared at retention times not related to the 
elution times of known standards.   
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Discussion 
Using two different analytical approaches, this project sought to confirm the presence of 
conjugated forms of artemisinic acid in whole plant tissues of A. annua.  Bulk extracts were 
purified according to the methods of Kawamoto et. al (1998), who isolated three glycosides of 
AA from suspension cells.  NMR analysis of the purified fractions of shoot and root extracts 
which corresponded to the fraction in which the glycosides were previously found did not at 
present result in the detection of any of the glycosides described by Kawamoto.  Results from the 
alternative experiments, however, indicated that under some conditions hydrolysis of shoot 
extracts apparently resulted in the liberation of AA, supporting the hypothesis that conjugated 
forms of AA exist in planta.   The results of both these experiments are discussed below. 
 
Putative Glycoside Isolation 
 
 The isolation of putative glycosides from bulk plant extracts was a daunting challenge 
from the start.  The procedure, as described in the literature by Kawamoto et al. (1998) was 
incomplete, vague, and (at least) partially incorrect, as was later discovered upon correspondence 
with the author (communications are compiled in Appendix A).  After multiple communications 
with the author via email, it seemed that the details of the more specific procedures (CC and 
HPLC) were clarified.  The procedure itself proved to be a time and resource-consuming 
endeavor, and the final NMR analysis of fractions was unfortunately limited by the duration of 
the project and the lack of a prep HPLC.  
The chemical procedure up to the point of column chromatography was consistent with a 
sequence of actions which would conserve glycosylated terpenoids, and it is unlikely that 
putative glycosides were removed from the extract before this point.  If the glycosides were in 
the residue when it was applied to the column, it is quite possible that they were eluted before the 
80:20 chloroform-methanol wash, for the majority of the applied residue was eluted in the 
previous fraction (90:10A) in both the shoot and root extracts.  Further, this was the fraction in 
which Kawamoto et al. (1998) observed the third glycoside which was only found in the spent 
cell culture medium.   
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The NMR analysis took much more time than expected, limiting the number of samples 
that could be analyzed.  Analysis was prioritized, and since the two glycosides extracted from 
suspension cells by Kawamoto et al. (1998) were found in the 80:20 fraction, this was the first 
and ultimately the only fraction to be analyzed.  The small amount of residue resulting from the 
isolation and purification of these fractions necessitated extensive analysis in order to produce 
interpretable data.  Dr. Erickson was unable to confirm anything that looked like terpenoids, or 
the compounds described by Kawamoto.  At the time of this writing, not all of the pooled 
fractions listed in the report have been fully analyzed.   
To complete this part of the study, the major residues from the 90:10 fractions should be 
purified and examined by NMR.  The second part of this study (the hydrolysis of extracts) 
indicated that glycosides may indeed be present, but only in the shoot tissues.  The 90:10 shoot 
fraction represents a large portion shoot biomass, and could contain the glycosides.  It is unlikely 
that glycosides were present only in undetectable amounts, because the starting plant biomass 
was much higher than the cell biomass extracted by Kawamoto et al. (1998), but this remains a 
possibility.  Alternatively, the glycosides may simply not exist in planta.  This however, 
challenges the results of the hydrolysis study, so the previous possibilities are more likely.  
Further, it is conceptually not possible to prove a negative result. 
Samples of the AA glycosides isolated by Kawamoto et al. (1998) would have been 
extremely helpful in the search for the compounds in planta.  Unfortunately the compounds were 
discarded some time after Dr. Kawamoto left the research facility.  There was no glycoside 
reference standard available for any of the targeted artemisinic acid glycosides.  Although 
organic synthesis of the glycosides is feasible (Mitsunobu Protocol, Batovska et al., 2005), it was 
not pursued in this project.  The synthesis was described by Sam Tang, a graduate-student 
organic chemist, as “relatively easy,” and should be considered in future studies of these 
glycosides.   
Enzymatic and Acid Hydrolysis of Putative AA Glycosides 
Although the results of the isolation procedure are as of yet, inconclusive, the hydrolysis 
study appears to support the presence of glycosylated artemisinic acid in shoots of A. annua.  
The hydrolysis of the authentic AB standard revealed interesting degradative effects which merit 
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further investigation.  Similarly, an apparent pH effect on the AA levels of washed shoot extracts 
must also be examined.  Hydrolysis of the washed shoot residues with glucosidase appeared to 
increase levels of AA.  The data indicates the presence of glycosylated forms of AA, as further 
discussed.   
Standard Treatments 
 The hydrolysis of the AA standard was performed to determine the effects of the 
treatment condition on the product (Figure 8).  When a small amount of the compound, 20 ug, 
was exposed to each of the conditions, only the acidic treatment caused much more degradation 
than the immediate extract.  The percent decrease in AA due to hot acid treatment was later used 
to adjust the value of AA seen in hot acid treated washed shoot residues, in order to obtain an 
estimate of how much AA was freed by the acid hydrolysis but subsequently destroyed by the 
procedure.   
 The treatment of AB standard yielded interesting and perplexing results.  It appears that 
AB is partially converted to AA upon solution in any of the aqueous conditions used in this 
experiment (Figure 9).  AA was not detected in the untreated sample, but was present in amounts 
which, in all the conditions without enzymes, could be accounted for by the amount of decrease 
in detected AB.  Upon inspection of the chemical structures of the two compounds, acid 
reduction of AB to AA seems quite plausible.  Further, the reaction that is known to convert AA 
to AB is a photo-oxidation reaction, which can occur in vitro (Roth and Acton, 1989).  One 
encounters a complication, however, when interpreting the AB standard treatment results, 
because the apparent increase in AA due to the enzyme treatments is far greater than the 
corresponding decrease in AB.  Further, the standards were not treated with the enzyme buffers 
alone, so the increase in putative AA can not be positively attributed to the enzymes.  The 
absorbance of AA and AB at 220 nm was roughly the same (within 10%), so it does not appear 
that that the areas of the HPLC chromatograms were misinterpreted.  Although the extent and 
nature of AB degradation to AA must be investigated further, it is clear that it is occurring to 
some extent, and must be taken into consideration when interpreting later results.   
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Hydrolysis of Whole Plant Residues 
 
The salt water wash procedure, performed in order to remove endogenous AA from a 
diethyl ether solution of shoot extract, appeared to be largely effective.  Previous studies had 
yielded concentrations in the range of 300 to 400 ug AA/g FW AA in unwashed air-dried leaf 
tissues.  Although the majority of endogenous AA appears to have been removed before 
hydrolysis treatment, all of the conditions involving an aqueous phase seem to have made more 
AA available.  The dramatic increase in AA upon solution and immediate extract with the neutral 
buffer was unexpected, and the source of this AA is unknown.  As explained in the results, the 
increases in AA can not be accounted for by the decreases in AB, except in the case of the 
averaged value of the esterase treatment (as explained in the results). Since the AA was 
identified solely by its retention time, it still needs to be confirmed as AA using NMR or MS.   
 The increased pools of AA must have been derived from the degradation of products 
other than AB which were also present in the washed extract.  Other sources of AA could include 
related artemisinic compounds or even the putative glycosides which are the subject of this study.  
There was an apparent pH effect on the amount of AA detected on immediate extracts, with pH 7 
buffer resulting in levels twice those found after treatment with pH 5.5 or pH 8.0 buffers.  The 
liberation of AA in aqueous extracts of shoot tissues and the effect of pH must be investigated, as 
these effects may complicate other studies of this compound.  More importantly, if this “new” 
AA truly is AA, then perhaps a novel reservoir has indeed been accessed.   
When enzyme treatments of washed shoot residues were compared to the enzyme-free 
incubated controls, the difference in AA suggested that the compound was made available 
because of treatment with the enzymes.   Although the β-glucosidase treatment was the only 
enzyme to show a repeated increase in AA (average 72%), one of the esterase samples suggest a 
substantial (88%) increase due to the enzyme (while the other sample exhibited degradation).  
The β-glucosidase used in this study (EC 3.2.1.21) hydrolyses terminal, non-reducing β-linked 
D-glucose residues.  This enzyme is more specific than the general carboxylic esterase also used 
in this study (EC 3.2.1.21).  In a similar hydrolysis study of salicylic acid glucosyl esters, Enyedi 
et al. (1992) reported cleavage due to β-glucosidase and no detectable change due to carboxyl 
esterase.   
The acid treatments of washed shoot residues indicate that some compound or group of 
compounds is being modified by the hot acid to yield an increase in AA.  The apparent increase 
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(especially when adjusted for AA degradation) is much larger than that seen in the enzyme 
treatments.  It appears that that whatever chemical species are being converted by acid, they are 
not entirely susceptible to enzymatic cleavage.  This makes sense, since a strong acid would be 
much more of a general reducing agent compared to an enzyme, and is likely degrading related 
artemisinic compounds.  Again, however, these increases in putative AA must be confirmed by 
NMR or MS.   
Although the effect of esterase on A. annua shoot extracts is unclear, the glucosidase 
treatment appears to have freed AA in washed shoot extracts, supporting the hypothesis that 
glycosylated forms of AA exist in planta.  If the increase in AA due to glucosidase is an 
indicator of the amount of glycosides found in the plant, then the increase indicates the presence 
of about 170 ug of glycoside per g FW.  If this figure is adjusted for the apparent degradation of 
AA due to the 90 minute incubation period (80.7%, from Table 3), then the value is 880 ug 
glycoside per g FW.  If this range of values is taken into consideration with the bulk of biomass 
extracted in the glycoside isolation procedure (521 g FW), then 89 to 460 mg of the glycoside 
should have been present in the crude extract.  As previously explained, not all fractions from the 
purification procedure have yet been analyzed.   
Because no increases in AA were observed upon hydrolysis of root extracts with either 
esterase or acid, the hypothesis that AA glycosides occur in root tissues of A. annua can not be 
supported.  However, the analysis of the root tissues may have been less than complete.  A subtle 
increase in absorbance at the retention time of AA may have been obscured by neighboring 
peaks.  To be sure that no AA was liberated due to hydrolysis treatments, the samples should be 
examined using a different mobile phase, or alternatively, using thin layer chromatography.   
As of this time, the hypothesis that AA glycosides exist in shoot tissues is supported, 
although the hypothesis of root production and transport of the glycosides is not.  The glycosides 
have not yet been isolated in planta, and the only indication of their presence is their apparent 
cleavage by β-glucosidase and acid hydrolysis, as indicated by increased pools of AA.   
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Appendix A- Full record of correspondence with Professor Kawamoto 
 
From: Marty <mdriggs@gmail.com>  
To: info@nisr.or.jp 
Date: May 14, 2005 7:12 PM 
Subject: Contact information for Mr. Hiroshi Sekine 
 
Greetings, 
My name is Martin Driggs.  I am a student at Worcester 
Polytechnic Institute in Massachussetts.  I am trying to contact 
Hiroshi Sekine. A 1998 publication in Phytochemistry  lists him 
as a contact for correspondence, and I have some questions for 
him.  If he is still at your institute, or if you have his 
information, please help me contact him (email is preferable). 
 
Thank you sincerely, 
Martin Driggs 
Worcester Polytechnic Institute 
 
From: 河本 啓 <hkawamoto@mail.kikkoman.co.jp>   
To: mdriggs@gmail.com 
Date: May 16, 2005 3:31 AM 
 
Dear Mr Driggs, 
 
Thank you for your e-mail of 14 May which has been forwarded to 
me. My name is Hiroshi Kawamoto. I had researched on artemisinin 
until 1999 at Noda Institute for Scientific Research. I am now 
working at Kikkoman Corp. which is related to the Institute. 
Since Mr Hiroshi Sekine had retired from the Institute, would 
you ask me questions about the publication ? 
 
Yours sincerely, 
Hiroshi Kawamoto 
Kikkoman Corp. 
hkawamoto@mail.kikkoman.co.jp 
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From: Marty <mdriggs@gmail.com>  
To: hkawamoto@mail.kikkoman.co.jp 
Date: May 16, 2005 6:16 PM 
Subject: Greetings Professor Kawamoto 
 
Greetings Professor Kawamoto, 
 
Thank you for replying so quickly to my email.  I am performing 
research on Artemisia annua in the Plant Tissue Culture 
Laboratory of Prof. Pam Weathers at WPI.  We are investigating 
the distribution of artemisinin and its precursors within 
tissues of the whole plants and in transformed roots.  I found 
your 1998 publication on sugar conjugates of artemisinic acid 
quite interesting, and I would like investigate the presence of 
such conjugates in the whole plants and transformed roots. 
However, I have several questions regarding your publication and 
would greatly appreciate your help. 
 
1.  Did you look for these compounds in any whole plant tissues? 
 
2.  Must the cells used for extractions be lyophilized, or will 
airdrying suffice? 
 
3.  In the creation of the C-BuOH fraction, are the cells 
extracted with EtOAc and then is that EtOAc fraction 
subsequently extracted with n-BuOH satd with H2O?  Or are these 
separate fractions? Please describe this process in more detail. 
 
4. What was the procedure for purification of the fractions 
using CC on silica gel? We are not organic chemists and need a 
bit more detail. 
 
5. For the HPLC,  what kind of detector was used, and at what 
wavelength?  What where the retention times and what standards 
wereused? 
 
Thank you for your time and any help you can supply.  I am 
looking forward to reading your responses and pursuing this 
investigation. 
 
Sincerely, 
 
Martin Driggs 
Worcester Polytechnic Institute 
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From: 河本 啓 <hkawamoto@mail.kikkoman.co.jp>   
To: mdriggs@gmail.com 
Date: May 26, 2005 4:23 AM 
Subject: Sorry for delay 
 
Dear Mr Driggs, 
 
Thank you for your interesting in my 1998 publication. I am not 
performing research on Artemisia now but I can help you by E-
mail with pleasure. 
 
>1.  Did you look for these compounds in any whole plant tissues? 
No, I did not and can not now. I hope you to do ! 
 
>2.  Must the cells used for extractions be lyophilized, or will 
air drying suffice? 
Air drying will be OK. 
 
>3.  In the creation of the C-BuOH fraction, are the 
cells >extracted with EtOAc and then is that EtOAc 
fraction >subsequently extracted with n-BuOH satd with H2O?  Or 
are these >separate fractions? Please describe this process in 
more detail. 
These are separate fractions. After EtOAc extraction, the 
residue was evaporated and extracted by n-BuOH satd with H2O. 
 
>4. What was the procedure for purification of the 
fractions >using CC on silica gel? We are not organic chemists 
and need a >bit more detail. 
This is a classical separation method. Silica gel (about 500 ml) 
was packed in a column. The compound "3" was eluted by 
Chloroform-MeOH (9:1)at the first 500 ml fraction. "4" and "5" 
were eluted by Chloroform-MeOH (8:2)at 500 ml - 900 ml fraction. 
But this separation step will not be necessary for purification 
(analysis) of a small amount of the compounds. 
 
>5. For the HPLC,  what kind of detector was used, and at what 
>wavelength?  What where the retention times and what 
standards >were used? 
The absorbance at 220 nm was always measured. RT of "3" was 20 
minute. RT of "4" and "5" were 29 and 22 minute, respectively. 
No standard was used. 
 
Sincerely, 
 
Hiroshi Kawamoto 
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Kikkoman Corp. 
hkawamoto@mail.kikkoman.co.jp 
From: Marty <mdriggs@gmail.com>   
To: 河本 啓 <hkawamoto@mail.kikkoman.co.jp> 
Date: Jun 20, 2005 11:31 AM 
Subject: Re: Sorry for delay 
 
Dear Professor Kawamoto, 
 
Thank you for your willingness to help me search for the 
artemisinic acid conjugates in whole plants.  I am still 
confused by some of the protocol and I hope you can take some 
time to answer several more questions for me.  I appreciate your 
help greatly.  Since I am looking for these compounds in the 
whole plants, with no liquid media, I will be looking for all 
three of the compounds in the tissue.  In your opinion, if they 
exist in the tissue, will I be able to isolate 3 and 4/5 
sequentially using a step gradient of elution buffer or must 
these isolations be performed on separate gels with separate 
extracts? 
 
1. Was the silica column chromatography wet (traditional) or dry? 
2. What were the dimensions of the column? 
3. What was the loading solvent for each silica column 
chromatography? 
4. What were the sample volumes for each column chromatography? 
5. What were the flow rates for each HPLC run? 
6. What were the injection solvents for each HPLC run? 
7. What was the injection volume for HPLC? 
 
Again, thank you much for your time. 
 
Sincerely, 
Martin 
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From: Marty <mdriggs@gmail.com>   
To: hkawamoto@mail.kikkoman.co.jp 
Cc: "Weathers, Pamela" <weathers@wpi.edu> 
Date: Dec 19, 2005 2:10 PM 
Subject: URGENT QUESTION on artemisinic glycosides 
 
Dear Professor Kawamoto, 
 
If you recall, I am searching for the artemisinic glycosides in 
whole plant tissues and earlier this year you helped me with 
some information on your analysis of biotransformation products 
in Artemisia annua. For that I am very grateful and my project 
is proceeding well. However, I have one more very crucial 
question. 
 
I am about to perform the HPLC purification step. However, our 
HPLC will not accommodate a prep-size column (injection loop 
size is limited to 0.2 ml), thus we have to scale down the 
separation to use a smaller column (longer, but much narrower) 
and do multiple injections to collect adequate product for 
NMR analysis. To do this my advisor, Professor Weathers and I 
have to do some calculations that will enable us to estimate the 
approximate elution VOLUME of the putative artemisinic 
glycosides using your HPLC method as a guide. Although you gave 
me the elution times, I can't translate them into volumes 
because I do not know the flow rate you used. Could you, 
therefore, please tell me what mobile phase flow rate (ml/min) 
you used on your prep column, so that we may calculate the 
expected elution volumes for the putative conjugates? I am 
trying to do the HPLC work in the next 2 weeks while I am on 
holiday break. 
 
Thank you for your reply, 
 
Martin Driggs, student 
and 
Professor Pamela J. Weathers 
Professor Biology and Biotechnology 
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From: 河本 啓 <hkawamoto@mail.kikkoman.co.jp>   
To: mdriggs@gmail.com 
Date: Dec 26, 2005 12:45 AM 
Subject: Re:URGENT QUESTION on artemisinic glycosides 
 
Dear Mr Driggs, 
 
I'm sorry to be late reply. 
The mobile phase flow rate for HPLC was always 1 ml/min. 
 
Good luck to your work and holiday. 
 
Sincerely, 
 
Hiroshi Kawamoto 
Kikkoman Corp. 
hkawamoto@mail.kikkoman.co.jp 
 
 
 
From: Weathers, Pamela <weathers@wpi.edu>   
To: hkawamoto@mail.kikkoman.co.jp 
Cc: Marty <mdriggs@gmail.com> 
Date: Jan 5, 2006 3:48 PM 
Subject: URGENT question!! 
 
Dear Dr. Kawamoto, 
  
We are now running our HPLC using a column that is 1/10 the 
volume of yours in all of its proportions. So we are scaling 
down everything to parallel your HPLC separation. However, it 
appears that all of your artemisinic glycosides eluted BEFORE 
the void volume!  
  
What solvent did you use to resuspend your samples for injection 
into the HPLC?  
  
Please let us know quickly so we can continue and thank you 
again for all of your help! 
  
Best regards, 
  
Pamela J. Weathers 
Professor Biology and Biotechnology 
Worcester Polytechnic Institute 
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Worcester, MA 01609 
  
From: hkawamoto@mail.kikkoman.co.jp  
To: Weathers, Pamela 
Date: Monday, January 09, 2006 9:26 PM 
Subject: Re:URGENT question!! 
 
Dear Dr. Driggs, 
 
I always used MeOH to resuspend samples for HPLC injection. But 
the solvent should have little influences on the retention time. 
I recommend you to change the elution solvent (ratio of 
MeCN:H2O). 
 
Sincerely, 
 
Hiroshi Kawamoto 
Kikkoman Corp. 
hkawamoto@mail.kikkoman.co.jp 
 
 
 
 
 
From: Weathers, Pamela 
To: 'hkawamoto@mail.kikkoman.co.jp' 
Date: Tuesday, January 10, 2006 1:09 PM 
Subject: RE your reply to our question 
 
 
Dear Dr. Kawamoto, 
 
Thank you for your helpful reply. When you say change the ratio 
of the mobile phase, to what? We were going to use your 
published mobile phase ratios of 1:4 and later 2:3, 
acetonitrile:water, but your message has given us pause. 
 
If you have other information helpful to us we would truly 
appreciate if you would share it with us. 
 
Also can you please explain how your retention times for the 
stated peaks were coming out before the void volume?  Which 
below describes how are you defining the retention time that you 
gave us for each of the artemisinic glycosides? Given your flow 
rate was 1 ml/min. then which is true, please? 
 
1) (Rt vol) = (Peak vol) - (void vol) 
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 OR 
2) (Rt vol) = (Peak vol) 
 
If it is the latter, then how is it possible for a peak 
retention volume to be LESS than the void volume of a column? I 
want to be sure we understand what you have shared with us in 
our effort to separate these unknown materials from our plant 
extracts. 
 
Thank you so much for your help! 
 
Regards, 
Pam Weathers 
Professor 
 
From: hkawamoto@mail.kikkoman.co.jp  
To: Weathers, Pamela 
Date: Thursday, January 12, 2006 1:36 AM 
Subject: RE your reply to our question 
 
Dear Dr. Driggs, 
 
I mean (Rt vol) = (Peak vol). 
Generally, RT is delicate as you know and can be caused by the 
column maker, 
the use history and so on. 
That's simply why I recommended to change a little the elution 
solvent. 
 
I do not understand how you identified the peaks coming out 
before the void 
volume to be the glycosides we found. 
Do you have the authentic samples? Shall I send ? 
 
Sincerely, 
 
Hiroshi Kawamoto 
Kikkoman Corp. 
hkawamoto@mail.kikkoman.co.jp 
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From: Weathers, Pamela <weathers@wpi.edu>   
To: hkawamoto@mail.kikkoman.co.jp 
Date: Jan 12, 2006 2:20 PM 
Subject: the confusion 
 
Dear Dr. Kawamoto, 
 
First I must say that I am Dr. Weathers, the faculty advisor for 
Mr. Driggs. Mr. Driggs is an undergraduate student in my lab. 
Sorry for any confusion. 
 
It would be wonderful if you could send us some of your 
authentic samples. It is very problematic as you know to work 
without any "standard". 
 
The reason I asked about the Void vol, Vo, is because my 
calculations of the Vo for the column (100mm height x 25 mm diam) 
you used (~70% of Vt) equals a Vo of about 35 ml. This is much 
higher than the Rt volumes that you gave us of 22 ml and 29 ml 
for # 4 and #5 AA glycosides, respectively, when flow rate 
was at 1 ml/min. So we were quite confused. Considering that 
there was no way for us to measure your Vo, we had to base our 
assumptions on this approximate calculation of Vo from the 
dimensions of your column. Thus, the reason for our questions 
(and confusion) is clear...I hope! 
 
Thank you again, 
Professor Pamela Weathers 
 
 
 
From: hkawamoto@mail.kikkoman.co.jp  
To: Weathers, Pamela 
Date: Friday, January 13, 2006 12:16 AM 
Subject: RE: the confusion 
 
Dear Professor Weathers 
 
I am very sorry for the confusion which was maybe caused by my 
low English ability. 
 
The HPLC flow rate of 1 ml/min and the retention times I 
informed are measured when samples were analyzed by a smaller 
analytical column (150mm height X 4.6mm diam). 
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The flow rate when the samples were injected into the larger 
separarion column (100mm height X 25mm diam) was 20 ml/min. The 
retention times are approximately the sames. 
 
Sincerely, 
 
Hiroshi Kawamoto 
Kikkoman Corp. 
hkawamoto@mail.kikkoman.co.jp 
 
 
 
 
 
 
 
From: "Weathers, Pamela" <weathers@WPI.EDU> 
To: <hkawamoto@mail.kikkoman.co.jp> 
Date: Fri, 13 Jan 2006 09:33:35 -0500 
 
Dear Dr. Kawamoto, 
 
Ahhhh yes now everything makes sense! By the way, I think that 
your English is fine. You should hear my very poor Japanese! 
 
Do you have any authentic samples left of those AA glycosides 
you isolated?  You mentioned earlier that you did. If you could 
send us some samples for comparison that would be very helpful! 
My mailing address is below. 
 
Thank you very much for the clarification. 
 
Best regards, 
Professor Pamela Weathers 
Biology and Biotechnology 
Worcester Polytechnic Institute 
100 Institute Rd. 
Worcester, MA 01609 
USA 
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From: hkawamoto@mail.kikkoman.co.jp  
Sent: Friday, January 20, 2006 4:10 AM 
To: Weathers, Pamela 
Subject: Bad news 
 
Dear Professor Weathers 
 
I am so sorry that I can not help you. 
We quitted the artemisinin research project 7 years ago and I 
have moved to other section where I work now. 
Yesterday, I visited the laboratory I worked before and looked 
for the authentic samples in the refrigerator. 
But I could not find. Who disposed my trasures !! 
 
Sincerely, 
 
Hiroshi Kawamoto 
Kikkoman Corp. 
hkawamoto@mail.kikkoman.co.jp 
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Appendix B- HPLC chromatograms from hydrolysis treatment conditions and replicates, 
presented in order of injection (left to right) 
 
 
 
sample name: washed shoots hot acid   sample name: washed shoots hot buffer (pH 7.0) 
injection volume: 100 ul     injection volume: 100 ul 
injection mass: 0.009 g FW     injection mass: 0.009 g FW 
mobile phase:  60:40 ACN-water    mobile phase:  60:40 ACN-water 
retention times of interest: 10.208 (9.94)   retention times of interest: 9.923 (9.867)  
and 7.648 (7.649) 
 
 
sample name: washed shoots acid room temp.   sample name: AB standard 
injection volume: 100 ul     injection volume: 50 ul 
injection mass: 0.009 g FW     injection mass: 2.5 ug 
mobile phase:  60:40 ACN-water    mobile phase:  60:40 ACN-water 
retention times of interest: 9.921 (9.914) and 7.649 (7.647) retention times of interest: 7.602 
 
 
 
 
 
 
 
 
 
 
1 
 
2 
 
3 
 
4 
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sample name: roots hot acid    sample name: roots hot buffer (pH 7.0) 
injection volume: 200 ul     injection volume: 200 ul 
injection mass: 0.12 g FW     injection mass: 0.12 g FW  
mobile phase:  60:40 ACN-water    mobile phase:  60:40 ACN-water 
retention times of interest:     retention times of interest: 
 
 
sample name: roots acid room temp.    sample name: AB standard hot acid 
injection volume: 200 ul     injection volume: 200 ul 
injection mass: 0.12 g FW     injection mass: 2 ug  
mobile phase:  60:40 ACN-water    mobile phase:  60:40 ACN-water 
retention times of interest:     retention times of interest: 9.797 (9.810) 
 
sample name: AB acid room temp.    sample name: AA standard  
injection volume: 200 ul     injection volume: 100 ul 
injection mass: 2 ug     injection mass: 1.5 ug  
mobile phase:  60:40 ACN-water    mobile phase:  60:40 ACN-water 
retention times of interest: 9.797 (9.807) and 7.571 (7.575) retention times of interest: 9.709 
 
5 
 
6 
 
7 
 8 
 
9 
 
10 
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sample name: AB Hot Buffer (pH 7.0)                sample name: washed shoots esterase buffer only (pH 8.0)  
injection volume: 200 ul     injection volume: 100 ul 
injection mass: 2 ug     injection mass: 0.009 g FW  
mobile phase:  60:40 ACN-water    mobile phase:  60:40 ACN-water 
retention times of interest: 9.818 (9.835) and 7.585 (7.602) retention times of interest: 9.760 (9.764) and 7.528 (7.533) 
 
sample name: washed shoots esterase         sample name: washed shoots glucosidase buffer only (pH 5.5)  
injection volume: 100 ul     injection volume: 100 ul 
injection mass: 0.009 g FW ug    injection mass: 0.009 g FW  
mobile phase:  60:40 ACN-water    mobile phase:  60:40 ACN-water 
retention times of interest: 9.781 and 7.543 (7.533)  retention times of interest: 9.78 (9.794) and 7.544 (7.557) 
 
 
 
sample name: washed shoots glucosidase (pH 5.5)  sample name: AB standard esterase (pH 8.0) 
injection volume: 100 ul     injection volume: 200 ul 
injection mass: 0.009 g FW ug    injection mass: 2 ug  
mobile phase:  60:40 ACN-water    mobile phase:  60:40 ACN-water 
retention times of interest: 9.783 (9.788) and 7.548 (7.551) retention times of interest: 9.903 (9.912) and 7.651 (7.660) 
11 
 
12 
 
13 
 
14 
 
15 
 16 
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sample name: AB standard glucosidase   sample name: roots esterase buffer only (pH 8.0) 
injection volume: 200 ul     injection volume: 200 ul 
injection mass: 2 ug     injection mass: 0.12 g FW  
mobile phase:  60:40 ACN-water    mobile phase:  60:40 ACN-water 
retention times of interest: 9.874 (9.857)   retention times of interest: 
 
 
sample name: roots esterase (pH 8.0)    sample name: washed shoots no treatment  
injection volume: 200 ul     injection volume: 100 ul 
injection mass: 0.12 g FW     injection mass: 0.009 g FW  
mobile phase:  60:40 ACN-water    mobile phase:  60:40 ACN-water 
retention times of interest:     retention times of interest: 9.583 (9.539) and 7.373 (7.364) 
 
sample name: roots no treatment    sample name: AB standard no treatment  
injection volume: 200 ul     injection volume: 200 ul 
injection mass: 0.12 g FW     injection mass: 2  ug 
mobile phase:  60:40 ACN-water    mobile phase:  60:40 ACN-water 
retention times of interest: 9.874 (9.857)   retention times of interest: 7.438 (7.446) 
17 
 
18 
 
19 
 
20 
 
21 
 
22 
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sample name: washed shoots immediate extract (pH 7.0)  sample name: washed shoots immediate extract (pH 8.0)  
injection volume: 100 ul     injection volume: 100 ul 
injection mass: 0.009 g FW ug    injection mass: 0.009 g FW  
mobile phase:  60:40 ACN-water    mobile phase:  60:40 ACN-water 
retention times of interest:9.524 (9.534) and 7.353 (7.362)  retention times of interest: 9.533 (9.539) and 7.359 (7.362) 
 
sample name: washed shoots immediate extract (pH 5.5)  sample name: roots immediate extract (pH 7.0)  
injection volume: 100 ul     injection volume: 200 ul 
injection mass: 0.009 g FW ug    injection mass: 0.12 g FW  
mobile phase:  60:40 ACN-water    mobile phase:  60:40 ACN-water 
retention times of interest: 9.538 (9.543) and 7.362 (7.366) retention times of interest:  
 
 
sample name: AB standard immediate extract (pH 7.0)  
injection volume: 200 ul 
injection mass: 2  ug 
mobile phase:  60:40 ACN-water 
retention times of interest: 7.472 (7.474) 
 
 
 
23 
 
24 
 
25 
 
26 
 
27 
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Appendix C 
The full set of data resulting from the analysis of HPLC chromatograms of hydrolysis treatment 
condition experiments, including the values for single-peak and double peak calculations, are 
presented in the following table. 
 
